PIAS3: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
imported>OAbot
m (Open access bot: add pmc identifier to citation with #oabot.)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''E3 SUMO-protein ligase PIAS3''' is an [[enzyme]] that in humans is encoded by the PIAS3 [[gene]].<ref name="pmid10319586">{{cite journal | vauthors = Ueki N, Seki N, Yano K, Saito T, Masuho Y, Muramatsu M | title = Isolation and chromosomal assignment of a human gene encoding protein inhibitor of activated STAT3 (PIAS3) | journal = Journal of Human Genetics | volume = 44 | issue = 3 | pages = 193–6 | date = June 1999 | pmid = 10319586 | pmc = | doi = 10.1007/s100380050141 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: PIAS3 protein inhibitor of activated STAT, 3| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10401| accessdate = }}</ref>
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
== PIAS family ==
{{GNF_Protein_box
| image =
| image_source =
| PDB =  
| Name = Protein inhibitor of activated STAT, 3
| HGNCid = 16861
| Symbol = PIAS3
| AltSymbols =; FLJ14651; ZMIZ5
| OMIM = 605987
| ECnumber = 
| Homologene = 4447
| MGIid = 1913126
| GeneAtlas_image1 = PBB_GE_PIAS3_203035_s_at_tn.png
| Function = {{GNF_GO|id=GO:0003676 |text = nucleic acid binding}} {{GNF_GO|id=GO:0003714 |text = transcription corepressor activity}} {{GNF_GO|id=GO:0005515 |text = protein binding}} {{GNF_GO|id=GO:0008270 |text = zinc ion binding}} {{GNF_GO|id=GO:0019789 |text = SUMO ligase activity}} {{GNF_GO|id=GO:0046872 |text = metal ion binding}}
| Component = {{GNF_GO|id=GO:0005634 |text = nucleus}}
| Process = {{GNF_GO|id=GO:0006350 |text = transcription}} {{GNF_GO|id=GO:0006355 |text = regulation of transcription, DNA-dependent}} {{GNF_GO|id=GO:0006512 |text = ubiquitin cycle}} {{GNF_GO|id=GO:0016925 |text = protein sumoylation}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 10401
    | Hs_Ensembl = ENSG00000131788
    | Hs_RefseqProtein = NP_006090
    | Hs_RefseqmRNA = NM_006099
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 1
    | Hs_GenLoc_start = 144287346
    | Hs_GenLoc_end = 144297903
    | Hs_Uniprot = Q9Y6X2
    | Mm_EntrezGene = 229615
    | Mm_Ensembl = ENSMUSG00000028101
    | Mm_RefseqmRNA = XM_925720
    | Mm_RefseqProtein = XP_930813
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 3
    | Mm_GenLoc_start = 96784822
    | Mm_GenLoc_end = 96791367
    | Mm_Uniprot = Q3TM95
  }}
}}
'''Protein inhibitor of activated STAT, 3''', also known as '''PIAS3''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: PIAS3 protein inhibitor of activated STAT, 3| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10401| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
The mammalian PIAS family consists of four members: PIAS1, PIAS2, PIAS3 and PIAS4. In Drosophila, a single PIAS homologue named dPIAS/Zimp has been identified.<ref>{{cite journal | vauthors = Mohr SE, Boswell RE | title = Zimp encodes a homologue of mouse Miz1 and PIAS3 and is an essential gene in Drosophila melanogaster | journal = Gene | volume = 229 | issue = 1-2 | pages = 109–16 | date = Mar 1999 | pmid = 10095110 | doi = 10.1016/s0378-1119(99)00033-5 }}</ref> In yeast, two  PIAS-related proteins were identified namely SIZ1 and SIZ2.<ref>{{cite journal | vauthors = Islam HK, Fujioka Y, Tomidokoro T, Sugiura H, Takahashi T, Kondo S, Katoh H | title = Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas | journal = Hepato-Gastroenterology | volume = 48 | issue = 39 | pages = 879-83 | year = 2001 | pmid = 11462947 }}</ref> The PIAS family contains more than 60 proteins, most of them transcription factors that can be either positively or negatively regulated through multiple mechanisms.
{{PBB_Summary
| section_title =  
| summary_text = This gene encodes a member of the PIAS [protein inhibitor of activated STAT (signal transducer and activator of transcription)] family of transcriptional modulators. The protein functions as a SUMO (small ubiquitin-like modifier)-E3 ligase which catalyzes the covalent attachment of a SUMO protein to specific target substrates. It directly binds to several transcription factors and either blocks or enhances their activity. Alternatively spliced transcript variants of this gene have been identified, but the full-length nature of some of these variants has not been determined.<ref name="entrez">{{cite web | title = Entrez Gene: PIAS3 protein inhibitor of activated STAT, 3| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10401| accessdate = }}</ref>
}}


==References==
== Discovery ==
{{reflist|2}}
 
==Further reading==
IAS proteins were originally identified in studies that were aimed to decipher the Janus Kinase (JAK)/STAT signaling pathway.  Originally, PIAS3 was found to interact specifically with phosphorylated STAT3 in Interleukin -6 (IL-6) activated murine myeloblast M1 cells.<ref>{{cite journal | vauthors = Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K | title = Specific inhibition of Stat3 signal transduction by PIAS3 | journal = Science | volume = 278 | issue = 5344 | pages = 1803–5 | date = Dec 1997 | pmid = 9388184 | doi = 10.1126/science.278.5344.1803 }}</ref> This interaction is mediated via PIAS3 binding to the STAT3 DNA binding domain. Hence, STAT3 transcriptional activity is inhibited by the physical prevention of its binding to target genes. Subsequently, PIAS3 was also found to be a regulator protein of other key transcription factors, including [[MITF]],<ref name = "Levy_2002">{{cite journal | vauthors = Levy C, Nechushtan H, Razin E | title = A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor | journal = The Journal of Biological Chemistry | volume = 277 | issue = 3 | pages = 1962–6 | date = Jan 2002 | pmid = 11709556 | doi = 10.1074/jbc.m109236200 }}</ref> [[NFκB]],<ref name = "Jang_2004">{{cite journal | vauthors = Jang HD, Yoon K, Shin YJ, Kim J, Lee SY | title = PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit | journal = The Journal of Biological Chemistry | volume = 279 | issue = 23 | pages = 24873–80 | date = Jun 2004 | pmid = 15140884 | doi = 10.1074/jbc.m313018200 }}</ref> [[SMAD (protein)|SMAD]]<ref name="pmid14681373">{{cite journal | vauthors = Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A | title = ProTherm, version 4.0: thermodynamic database for proteins and mutants | journal = Nucleic Acids Research | volume = 32 | issue = Database issue | pages = D120–1 | year = 2004 | pmid = 14681373 | pmc = 308816 | doi = 10.1093/nar/gkh082 }}</ref> and estrogen receptor.<ref name="pmid15961505">{{cite journal | vauthors = Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L | title = Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity | journal = Molecular Endocrinology (Baltimore, Md.) | volume = 19 | issue = 11 | pages = 2671–84 | year = 2005 | pmid = 15961505 | doi = 10.1210/me.2005-0042 }}</ref>
{{refbegin | 2}}
 
{{PBB_Further_reading
== Function ==
| citations =
 
*{{cite journal | author=Chung CD, Liao J, Liu B, ''et al.'' |title=Specific inhibition of Stat3 signal transduction by PIAS3. |journal=Science |volume=278 |issue= 5344 |pages= 1803-5 |year= 1997 |pmid= 9388184 |doi= }}
PIAS3 protein also functions  as a SUMO (small ubiquitin-like modifier)-E3 ligase which catalyzes the covalent attachment of a SUMO protein to specific target substrates. It directly binds to several transcription factors and either blocks or enhances their activity. Alternatively spliced transcript variants of this gene have been identified, but the full-length nature of some of these variants has not been determined.<ref name="entrez" />
*{{cite journal | author=Ueki N, Seki N, Yano K, ''et al.'' |title=Isolation and chromosomal assignment of a human gene encoding protein inhibitor of activated STAT3 (PIAS3). |journal=J. Hum. Genet. |volume=44 |issue= 3 |pages= 193-6 |year= 1999 |pmid= 10319586 |doi= }}
 
*{{cite journal | author=Rödel B, Tavassoli K, Karsunky H, ''et al.'' |title=The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. |journal=EMBO J. |volume=19 |issue= 21 |pages= 5845-55 |year= 2000 |pmid= 11060035 |doi= 10.1093/emboj/19.21.5845 }}
== Domains ==
*{{cite journal | author=Junicho A, Matsuda T, Yamamoto T, ''et al.'' |title=Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. |journal=Biochem. Biophys. Res. Commun. |volume=278 |issue= 1 |pages= 9-13 |year= 2001 |pmid= 11071847 |doi= 10.1006/bbrc.2000.3753 }}
 
*{{cite journal | author=Kotaja N, Aittomäki S, Silvennoinen O, ''et al.'' |title=ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. |journal=Mol. Endocrinol. |volume=14 |issue= 12 |pages= 1986-2000 |year= 2001 |pmid= 11117529 |doi= }}
The SAF-A/B, Acinus and PIAS (SAP) domain is located at the N-terminal of PIAS proteins.<ref>{{cite journal | vauthors = Shuai K | title = Regulation of cytokine signaling pathways by PIAS proteins | journal = Cell Research | volume = 16 | issue = 2 | pages = 196–202 | date = Feb 2006 | pmid = 16474434 | doi = 10.1038/sj.cr.7310027 }}</ref> This evolutionarily conserved domain is found in proteins ranging from yeast to human and is shared by other chromatin-binding proteins, such as scaffold attachment factor A and B.<ref name="pmid10694879">{{cite journal | vauthors = Aravind L, Koonin EV | title = SAP - a putative DNA-binding motif involved in chromosomal organization | journal = Trends in Biochemical Sciences | volume = 25 | issue = 3 | pages = 112–4 | year = 2000 | pmid = 10694879 | doi = 10.1016/s0968-0004(99)01537-6}}</ref> The SAP domain can recognize and bind to AT-rich DNA sequences present in scaffold-attachment regions/matrix-attachment regions.<ref>{{cite journal | last1 = Kipp | first1 = M. | display-authors = etal  | year = 2000 | title = SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA | url = | journal = Mol Cell Biol | volume = 20 | issue = | pages = 7480–7489 | doi=10.1128/mcb.20.20.7480-7489.2000| pmc = 86301}}</ref> These elements are frequently found near gene enhancers and interact with nuclear matrix proteins to provide a unique nuclear microenvironment for transcriptional regulation. An LXXLL signature motif is present within the SAP domain of all PIAS proteins. This signature motif has been shown to mediate interactions between nuclear receptors and their co-regulators.<ref>{{cite journal | vauthors = Glass CK, Rosenfeld MG | title = The coregulator exchange in transcriptional functions of nuclear receptors | journal = Genes & Development | volume = 14 | issue = 2 | pages = 121–41 | date = Jan 2000 | pmid = 10652267 | doi = 10.1101/gad.14.2.121 }}</ref> It is also essential for the binding of PIAS3 to androgen receptor. The LXXLL motif represents the minimal requirement for the interaction with the NFκB p65 subunit and for the inhibition of NFκB transcriptional activity.<ref name = "Jang_2004"/> It was previously described that the LXXLL motif is also responsible for the retention of PIAS3 in the nucleus.
*{{cite journal  | author=Zentner MD, Lin HH, Deng HT, ''et al.'' |title=Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells. |journal=J. Biol. Chem. |volume=276 |issue= 32 |pages= 29805-14 |year= 2001 |pmid= 11390395 |doi= 10.1074/jbc.M103153200 }}
 
*{{cite journal | author=Wang LH, Yang XY, Mihalic K, ''et al.'' |title=Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3. |journal=J. Biol. Chem. |volume=276 |issue= 34 |pages= 31839-44 |year= 2001 |pmid= 11429412 |doi= 10.1074/jbc.M105185200 }}
The Pro-Ile-Asn-Ile-Thr (PINIT) motif represents a highly conserved region of PIAS proteins, which was shown to be involved in the nuclear retention of PIAS3.<ref>{{cite journal | vauthors = Duval D, Duval G, Kedinger C, Poch O, Boeuf H | title = The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L | journal = FEBS Letters | volume = 554 | issue = 1-2 | pages = 111–8 | date = Nov 2003 | pmid = 14596924 | doi = 10.1016/s0014-5793(03)01116-5 }}</ref> Within the PINIT domain, the PIAS382-132 region was isolated and characterized as an inhibitory domain that binds and inhibits both the MITF and STAT3 transcription factors.<ref>{{cite journal | vauthors = Levy C, Khaled M, Fisher DE | title = MITF: master regulator of melanocyte development and melanoma oncogene | journal = Trends in Molecular Medicine | volume = 12 | issue = 9 | pages = 406–14 | date = Sep 2006 | pmid = 16899407 | doi = 10.1016/j.molmed.2006.07.008 }}</ref> The RING-finger-like zinc-binding domain (RLD) is one of the most conserved domains of the PIAS family and has been shown to be important for PIAS3 activity as a SUMO-E3 ligase.<ref>{{cite journal | last1 = Nakagawa | first1 = K. | last2 = Yokosawa | first2 = H. | year = 2002 | title = PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1 | url = | journal = FEBS Lett | volume = 530 | issue = | pages = 204–208 | doi=10.1016/s0014-5793(02)03486-5 | pmid=12387893}}</ref> The RLD domain is also involved in the positive regulation of SMAD3 by PIAS3.<ref>{{cite journal | vauthors = Long J, Wang G, Matsuura I, He D, Liu F | title = Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3) | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 101 | issue = 1 | pages = 99–104 | date = Jan 2004 | pmid = 14691252 | pmc = 314145 | doi = 10.1073/pnas.0307598100 }}</ref>
*{{cite journal  | author=Levy C, Nechushtan H, Razin E |title=A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. |journal=J. Biol. Chem. |volume=277 |issue= 3 |pages= 1962-6 |year= 2002 |pmid= 11709556 |doi= 10.1074/jbc.M109236200 }}
 
*{{cite journal | author=Jiménez-Lara AM, Heine MJ, Gronemeyer H |title=PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. |journal=FEBS Lett. |volume=526 |issue= 1-3 |pages= 142-6 |year= 2002 |pmid= 12208521 |doi= }}
== Interactions ==
*{{cite journal | author=Nakagawa K, Yokosawa H |title=PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. |journal=FEBS Lett. |volume=530 |issue= 1-3 |pages= 204-8 |year= 2002 |pmid= 12387893 |doi= }}
 
*{{cite journal  | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
PIAS3 has been shown to [[Protein-protein interaction|interact]] with:
*{{cite journal | author=Yamamoto T, Sato N, Sekine Y, ''et al.'' |title=Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor. |journal=Biochem. Biophys. Res. Commun. |volume=306 |issue= 2 |pages= 610-5 |year= 2003 |pmid= 12804609 |doi= }}
{{div col|colwidth=20em}}
*{{cite journal | author=Di Y, Li J, Zhang Y, ''et al.'' |title=HCC-associated protein HCAP1, a variant of GEMIN4, interacts with zinc-finger proteins. |journal=J. Biochem. |volume=133 |issue= 6 |pages= 713-8 |year= 2004 |pmid= 12869526 |doi=  }}
* [[GFI1]],<ref name = pmid11060035>{{cite journal | vauthors = Rödel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, Schaper F, Heinrich P, Shuai K, Elsässer HP, Möröy T | date = Nov 2000 | title = The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3 | journal = EMBO J. | volume = 19 | issue = 21 | pages = 5845-55 | pmid = 11060035 | pmc = 305799 | doi = 10.1093/emboj/19.21.5845}}</ref>
*{{cite journal | author=Cheng J, Zhang D, Zhou C, Marasco WA |title=Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells. |journal=Leuk. Res. |volume=28 |issue= 1 |pages= 71-82 |year= 2004 |pmid= 14630083 |doi= }}
* [[HMGA2]]<ref name = pmid11390395>{{cite journal | vauthors = Zentner MD, Lin HH, Deng HT, Kim KJ, Shih HM, Ann DK | date = Aug 2001 | title = Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells | journal = J. Biol. Chem. | volume = 276 | issue = 32 | pages = 29805-14 | pmid = 11390395 | doi = 10.1074/jbc.M103153200}}</ref>
*{{cite journal  | author=Long J, Wang G, Matsuura I, ''et al.'' |title=Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue= 1 |pages= 99-104 |year= 2004 |pmid= 14691252 |doi= 10.1073/pnas.0307598100 }}
* [[Microphthalmia-associated transcription factor|MITF]],<ref name = "Levy_2002"/><ref>{{cite journal | vauthors = Yagil Z, Nechushtan H, Kay G, Yang CM, Kemeny DM, Razin E | date = May 2010 | title = The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response | journal = Trends Immunol. | volume = 31 | issue = 5 | pages = 199-204 | pmid = 20181527 | doi = 10.1016/j.it.2010.01.005}}</ref>
*{{cite journal | author=Ota T, Suzuki Y, Nishikawa T, ''et al.'' |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40-5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }}
* [[Mothers against decapentaplegic homolog 2|SMAD2]],<ref name = pmid14691252/>
*{{cite journal | author=Nojiri S, Joh T, Miura Y, ''et al.'' |title=ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. |journal=Biochem. Biophys. Res. Commun. |volume=314 |issue= 1 |pages= 97-103 |year= 2004 |pmid= 14715251 |doi= }}
* [[Mothers against decapentaplegic homolog 3|SMAD3]],<ref name = pmid14691252>{{cite journal | vauthors = Long J, Wang G, Matsuura I, He D, Liu F | date = Jan 2004 | title = Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3) | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 101 | issue = 1 | pages = 99-104 | pmid = 14691252 | pmc = 314145 | doi = 10.1073/pnas.0307598100}}</ref>  and
*{{cite journal | author=Wang L, Banerjee S |title=Differential PIAS3 expression in human malignancy. |journal=Oncol. Rep. |volume=11 |issue= 6 |pages= 1319-24 |year= 2004 |pmid= 15138572 |doi= }}
* [[RELA]].<ref name = "Jang_2004"/>
*{{cite journal | author=Jang HD, Yoon K, Shin YJ, ''et al.'' |title=PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. |journal=J. Biol. Chem. |volume=279 |issue= 23 |pages= 24873-80 |year= 2004 |pmid= 15140884 |doi= 10.1074/jbc.M313018200 }}
{{Div col end}}
*{{cite journal | author=Colland F, Jacq X, Trouplin V, ''et al.'' |title=Functional proteomics mapping of a human signaling pathway. |journal=Genome Res. |volume=14 |issue= 7 |pages= 1324-32 |year= 2004 |pmid= 15231748 |doi= 10.1101/gr.2334104 }}
 
}}
==Related gene problems==
*[[TAR syndrome]]<ref name="pmid17236129">{{cite journal | vauthors = Klopocki E, Schulze H, Strauss G, Ott CE, Hall J, Trotier F, Fleischhauer S, Greenhalgh L, Newbury-Ecob RA, Neumann LM, Habenicht R, König R, Seemanova E, Megarbane A, Ropers HH, Ullmann R, Horn D, Mundlos S | title = Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome | journal = American Journal of Human Genetics | volume = 80 | issue = 2 | pages = 232–40 | date = Feb 2007 | pmid = 17236129 | pmc = 1785342 | doi = 10.1086/510919 }}</ref>
*[[1q21.1 deletion syndrome]]
*[[1q21.1 duplication syndrome]]
 
== References ==
{{reflist|33em}}
 
== Further reading ==
{{refbegin|33em}}
* {{cite journal | vauthors = Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K | title = Specific inhibition of Stat3 signal transduction by PIAS3 | journal = Science | volume = 278 | issue = 5344 | pages = 1803–5 | date = Dec 1997 | pmid = 9388184 | doi = 10.1126/science.278.5344.1803 }}
* {{cite journal | vauthors = Rödel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, Schaper F, Heinrich P, Shuai K, Elsässer HP, Möröy T | title = The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3 | journal = The EMBO Journal | volume = 19 | issue = 21 | pages = 5845–55 | date = Nov 2000 | pmid = 11060035 | pmc = 305799 | doi = 10.1093/emboj/19.21.5845 }}
* {{cite journal | vauthors = Junicho A, Matsuda T, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H, Muraguchi A | title = Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells | journal = Biochemical and Biophysical Research Communications | volume = 278 | issue = 1 | pages = 9–13 | date = Nov 2000 | pmid = 11071847 | doi = 10.1006/bbrc.2000.3753 }}
* {{cite journal | vauthors = Kotaja N, Aittomäki S, Silvennoinen O, Palvimo JJ, Jänne OA | title = ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation | journal = Molecular Endocrinology | volume = 14 | issue = 12 | pages = 1986–2000 | date = Dec 2000 | pmid = 11117529 | doi = 10.1210/mend.14.12.0569 }}
* {{cite journal | vauthors = Zentner MD, Lin HH, Deng HT, Kim KJ, Shih HM, Ann DK | title = Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells | journal = The Journal of Biological Chemistry | volume = 276 | issue = 32 | pages = 29805–14 | date = Aug 2001 | pmid = 11390395 | doi = 10.1074/jbc.M103153200 }}
* {{cite journal | vauthors = Wang LH, Yang XY, Mihalic K, Xiao W, Li D, Farrar WL | title = Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3 | journal = The Journal of Biological Chemistry | volume = 276 | issue = 34 | pages = 31839–44 | date = Aug 2001 | pmid = 11429412 | doi = 10.1074/jbc.M105185200 }}
* {{cite journal | vauthors = Jiménez-Lara AM, Heine MJ, Gronemeyer H | title = PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2 | journal = FEBS Letters | volume = 526 | issue = 1-3 | pages = 142–6 | date = Aug 2002 | pmid = 12208521 | doi = 10.1016/S0014-5793(02)03154-X }}
* {{cite journal | vauthors = Nakagawa K, Yokosawa H | title = PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1 | journal = FEBS Letters | volume = 530 | issue = 1-3 | pages = 204–8 | date = Oct 2002 | pmid = 12387893 | doi = 10.1016/S0014-5793(02)03486-5 }}
* {{cite journal | vauthors = Yamamoto T, Sato N, Sekine Y, Yumioka T, Imoto S, Junicho A, Fuse H, Matsuda T | title = Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor | journal = Biochemical and Biophysical Research Communications | volume = 306 | issue = 2 | pages = 610–5 | date = Jun 2003 | pmid = 12804609 | doi = 10.1016/S0006-291X(03)01026-X }}
* {{cite journal | vauthors = Di Y, Li J, Zhang Y, He X, Lu H, Xu D, Ling J, Huo K, Wan D, Li YY, Gu J | title = HCC-associated protein HCAP1, a variant of GEMIN4, interacts with zinc-finger proteins | journal = Journal of Biochemistry | volume = 133 | issue = 6 | pages = 713–8 | date = Jun 2003 | pmid = 12869526 | doi = 10.1093/jb/mvg091 }}
* {{cite journal | vauthors = Cheng J, Zhang D, Zhou C, Marasco WA | title = Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells | journal = Leukemia Research | volume = 28 | issue = 1 | pages = 71–82 | date = Jan 2004 | pmid = 14630083 | doi = 10.1016/S0145-2126(03)00158-9 }}
* {{cite journal | vauthors = Long J, Wang G, Matsuura I, He D, Liu F | title = Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3) | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 101 | issue = 1 | pages = 99–104 | date = Jan 2004 | pmid = 14691252 | pmc = 314145 | doi = 10.1073/pnas.0307598100 }}
* {{cite journal | vauthors = Nojiri S, Joh T, Miura Y, Sakata N, Nomura T, Nakao H, Sobue S, Ohara H, Asai K, Ito M | title = ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3 | journal = Biochemical and Biophysical Research Communications | volume = 314 | issue = 1 | pages = 97–103 | date = Jan 2004 | pmid = 14715251 | doi = 10.1016/j.bbrc.2003.12.054 }}
* {{cite journal | vauthors = Wang L, Banerjee S | title = Differential PIAS3 expression in human malignancy | journal = Oncology Reports | volume = 11 | issue = 6 | pages = 1319–24 | date = Jun 2004 | pmid = 15138572 | doi = 10.3892/or.11.6.1319 }}
* {{cite journal | vauthors = Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, Meil A, Wojcik J, Legrain P, Gauthier JM | title = Functional proteomics mapping of a human signaling pathway | journal = Genome Research | volume = 14 | issue = 7 | pages = 1324–32 | date = Jul 2004 | pmid = 15231748 | pmc = 442148 | doi = 10.1101/gr.2334104 }}
{{refend}}
{{refend}}


{{protein-stub}}
{{JAK-STAT signaling pathway}}
{{WikiDoc Sources}}

Latest revision as of 15:58, 15 May 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

E3 SUMO-protein ligase PIAS3 is an enzyme that in humans is encoded by the PIAS3 gene.[1][2]

PIAS family

The mammalian PIAS family consists of four members: PIAS1, PIAS2, PIAS3 and PIAS4. In Drosophila, a single PIAS homologue named dPIAS/Zimp has been identified.[3] In yeast, two PIAS-related proteins were identified namely SIZ1 and SIZ2.[4] The PIAS family contains more than 60 proteins, most of them transcription factors that can be either positively or negatively regulated through multiple mechanisms.

Discovery

IAS proteins were originally identified in studies that were aimed to decipher the Janus Kinase (JAK)/STAT signaling pathway. Originally, PIAS3 was found to interact specifically with phosphorylated STAT3 in Interleukin -6 (IL-6) activated murine myeloblast M1 cells.[5] This interaction is mediated via PIAS3 binding to the STAT3 DNA binding domain. Hence, STAT3 transcriptional activity is inhibited by the physical prevention of its binding to target genes. Subsequently, PIAS3 was also found to be a regulator protein of other key transcription factors, including MITF,[6] NFκB,[7] SMAD[8] and estrogen receptor.[9]

Function

PIAS3 protein also functions as a SUMO (small ubiquitin-like modifier)-E3 ligase which catalyzes the covalent attachment of a SUMO protein to specific target substrates. It directly binds to several transcription factors and either blocks or enhances their activity. Alternatively spliced transcript variants of this gene have been identified, but the full-length nature of some of these variants has not been determined.[2]

Domains

The SAF-A/B, Acinus and PIAS (SAP) domain is located at the N-terminal of PIAS proteins.[10] This evolutionarily conserved domain is found in proteins ranging from yeast to human and is shared by other chromatin-binding proteins, such as scaffold attachment factor A and B.[11] The SAP domain can recognize and bind to AT-rich DNA sequences present in scaffold-attachment regions/matrix-attachment regions.[12] These elements are frequently found near gene enhancers and interact with nuclear matrix proteins to provide a unique nuclear microenvironment for transcriptional regulation. An LXXLL signature motif is present within the SAP domain of all PIAS proteins. This signature motif has been shown to mediate interactions between nuclear receptors and their co-regulators.[13] It is also essential for the binding of PIAS3 to androgen receptor. The LXXLL motif represents the minimal requirement for the interaction with the NFκB p65 subunit and for the inhibition of NFκB transcriptional activity.[7] It was previously described that the LXXLL motif is also responsible for the retention of PIAS3 in the nucleus.

The Pro-Ile-Asn-Ile-Thr (PINIT) motif represents a highly conserved region of PIAS proteins, which was shown to be involved in the nuclear retention of PIAS3.[14] Within the PINIT domain, the PIAS382-132 region was isolated and characterized as an inhibitory domain that binds and inhibits both the MITF and STAT3 transcription factors.[15] The RING-finger-like zinc-binding domain (RLD) is one of the most conserved domains of the PIAS family and has been shown to be important for PIAS3 activity as a SUMO-E3 ligase.[16] The RLD domain is also involved in the positive regulation of SMAD3 by PIAS3.[17]

Interactions

PIAS3 has been shown to interact with:

Related gene problems

References

  1. ↑ Ueki N, Seki N, Yano K, Saito T, Masuho Y, Muramatsu M (June 1999). "Isolation and chromosomal assignment of a human gene encoding protein inhibitor of activated STAT3 (PIAS3)". Journal of Human Genetics. 44 (3): 193–6. doi:10.1007/s100380050141. PMID 10319586.
  2. ↑ 2.0 2.1 "Entrez Gene: PIAS3 protein inhibitor of activated STAT, 3".
  3. ↑ Mohr SE, Boswell RE (Mar 1999). "Zimp encodes a homologue of mouse Miz1 and PIAS3 and is an essential gene in Drosophila melanogaster". Gene. 229 (1–2): 109–16. doi:10.1016/s0378-1119(99)00033-5. PMID 10095110.
  4. ↑ Islam HK, Fujioka Y, Tomidokoro T, Sugiura H, Takahashi T, Kondo S, Katoh H (2001). "Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas". Hepato-Gastroenterology. 48 (39): 879–83. PMID 11462947.
  5. ↑ Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K (Dec 1997). "Specific inhibition of Stat3 signal transduction by PIAS3". Science. 278 (5344): 1803–5. doi:10.1126/science.278.5344.1803. PMID 9388184.
  6. ↑ 6.0 6.1 Levy C, Nechushtan H, Razin E (Jan 2002). "A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor". The Journal of Biological Chemistry. 277 (3): 1962–6. doi:10.1074/jbc.m109236200. PMID 11709556.
  7. ↑ 7.0 7.1 7.2 Jang HD, Yoon K, Shin YJ, Kim J, Lee SY (Jun 2004). "PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit". The Journal of Biological Chemistry. 279 (23): 24873–80. doi:10.1074/jbc.m313018200. PMID 15140884.
  8. ↑ Bava KA, Gromiha MM, Uedaira H, Kitajima K, Sarai A (2004). "ProTherm, version 4.0: thermodynamic database for proteins and mutants". Nucleic Acids Research. 32 (Database issue): D120–1. doi:10.1093/nar/gkh082. PMC 308816. PMID 14681373.
  9. ↑ Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L (2005). "Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity". Molecular Endocrinology (Baltimore, Md.). 19 (11): 2671–84. doi:10.1210/me.2005-0042. PMID 15961505.
  10. ↑ Shuai K (Feb 2006). "Regulation of cytokine signaling pathways by PIAS proteins". Cell Research. 16 (2): 196–202. doi:10.1038/sj.cr.7310027. PMID 16474434.
  11. ↑ Aravind L, Koonin EV (2000). "SAP - a putative DNA-binding motif involved in chromosomal organization". Trends in Biochemical Sciences. 25 (3): 112–4. doi:10.1016/s0968-0004(99)01537-6. PMID 10694879.
  12. ↑ Kipp, M.; et al. (2000). "SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA". Mol Cell Biol. 20: 7480–7489. doi:10.1128/mcb.20.20.7480-7489.2000. PMC 86301.
  13. ↑ Glass CK, Rosenfeld MG (Jan 2000). "The coregulator exchange in transcriptional functions of nuclear receptors". Genes & Development. 14 (2): 121–41. doi:10.1101/gad.14.2.121. PMID 10652267.
  14. ↑ Duval D, Duval G, Kedinger C, Poch O, Boeuf H (Nov 2003). "The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L". FEBS Letters. 554 (1–2): 111–8. doi:10.1016/s0014-5793(03)01116-5. PMID 14596924.
  15. ↑ Levy C, Khaled M, Fisher DE (Sep 2006). "MITF: master regulator of melanocyte development and melanoma oncogene". Trends in Molecular Medicine. 12 (9): 406–14. doi:10.1016/j.molmed.2006.07.008. PMID 16899407.
  16. ↑ Nakagawa, K.; Yokosawa, H. (2002). "PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1". FEBS Lett. 530: 204–208. doi:10.1016/s0014-5793(02)03486-5. PMID 12387893.
  17. ↑ Long J, Wang G, Matsuura I, He D, Liu F (Jan 2004). "Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3)". Proceedings of the National Academy of Sciences of the United States of America. 101 (1): 99–104. doi:10.1073/pnas.0307598100. PMC 314145. PMID 14691252.
  18. ↑ Rödel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, Schaper F, Heinrich P, Shuai K, Elsässer HP, Möröy T (Nov 2000). "The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3". EMBO J. 19 (21): 5845–55. doi:10.1093/emboj/19.21.5845. PMC 305799. PMID 11060035.
  19. ↑ Zentner MD, Lin HH, Deng HT, Kim KJ, Shih HM, Ann DK (Aug 2001). "Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells". J. Biol. Chem. 276 (32): 29805–14. doi:10.1074/jbc.M103153200. PMID 11390395.
  20. ↑ Yagil Z, Nechushtan H, Kay G, Yang CM, Kemeny DM, Razin E (May 2010). "The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response". Trends Immunol. 31 (5): 199–204. doi:10.1016/j.it.2010.01.005. PMID 20181527.
  21. ↑ 21.0 21.1 Long J, Wang G, Matsuura I, He D, Liu F (Jan 2004). "Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3)". Proc. Natl. Acad. Sci. U.S.A. 101 (1): 99–104. doi:10.1073/pnas.0307598100. PMC 314145. PMID 14691252.
  22. ↑ Klopocki E, Schulze H, Strauss G, Ott CE, Hall J, Trotier F, Fleischhauer S, Greenhalgh L, Newbury-Ecob RA, Neumann LM, Habenicht R, König R, Seemanova E, Megarbane A, Ropers HH, Ullmann R, Horn D, Mundlos S (Feb 2007). "Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome". American Journal of Human Genetics. 80 (2): 232–40. doi:10.1086/510919. PMC 1785342. PMID 17236129.

Further reading

  • Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K (Dec 1997). "Specific inhibition of Stat3 signal transduction by PIAS3". Science. 278 (5344): 1803–5. doi:10.1126/science.278.5344.1803. PMID 9388184.
  • Rödel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, Schaper F, Heinrich P, Shuai K, Elsässer HP, Möröy T (Nov 2000). "The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3". The EMBO Journal. 19 (21): 5845–55. doi:10.1093/emboj/19.21.5845. PMC 305799. PMID 11060035.
  • Junicho A, Matsuda T, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H, Muraguchi A (Nov 2000). "Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells". Biochemical and Biophysical Research Communications. 278 (1): 9–13. doi:10.1006/bbrc.2000.3753. PMID 11071847.
  • Kotaja N, Aittomäki S, Silvennoinen O, Palvimo JJ, Jänne OA (Dec 2000). "ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation". Molecular Endocrinology. 14 (12): 1986–2000. doi:10.1210/mend.14.12.0569. PMID 11117529.
  • Zentner MD, Lin HH, Deng HT, Kim KJ, Shih HM, Ann DK (Aug 2001). "Requirement for high mobility group protein HMGI-C interaction with STAT3 inhibitor PIAS3 in repression of alpha-subunit of epithelial Na+ channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells". The Journal of Biological Chemistry. 276 (32): 29805–14. doi:10.1074/jbc.M103153200. PMID 11390395.
  • Wang LH, Yang XY, Mihalic K, Xiao W, Li D, Farrar WL (Aug 2001). "Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3". The Journal of Biological Chemistry. 276 (34): 31839–44. doi:10.1074/jbc.M105185200. PMID 11429412.
  • Jiménez-Lara AM, Heine MJ, Gronemeyer H (Aug 2002). "PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2". FEBS Letters. 526 (1–3): 142–6. doi:10.1016/S0014-5793(02)03154-X. PMID 12208521.
  • Nakagawa K, Yokosawa H (Oct 2002). "PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1". FEBS Letters. 530 (1–3): 204–8. doi:10.1016/S0014-5793(02)03486-5. PMID 12387893.
  • Yamamoto T, Sato N, Sekine Y, Yumioka T, Imoto S, Junicho A, Fuse H, Matsuda T (Jun 2003). "Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor". Biochemical and Biophysical Research Communications. 306 (2): 610–5. doi:10.1016/S0006-291X(03)01026-X. PMID 12804609.
  • Di Y, Li J, Zhang Y, He X, Lu H, Xu D, Ling J, Huo K, Wan D, Li YY, Gu J (Jun 2003). "HCC-associated protein HCAP1, a variant of GEMIN4, interacts with zinc-finger proteins". Journal of Biochemistry. 133 (6): 713–8. doi:10.1093/jb/mvg091. PMID 12869526.
  • Cheng J, Zhang D, Zhou C, Marasco WA (Jan 2004). "Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells". Leukemia Research. 28 (1): 71–82. doi:10.1016/S0145-2126(03)00158-9. PMID 14630083.
  • Long J, Wang G, Matsuura I, He D, Liu F (Jan 2004). "Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3)". Proceedings of the National Academy of Sciences of the United States of America. 101 (1): 99–104. doi:10.1073/pnas.0307598100. PMC 314145. PMID 14691252.
  • Nojiri S, Joh T, Miura Y, Sakata N, Nomura T, Nakao H, Sobue S, Ohara H, Asai K, Ito M (Jan 2004). "ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3". Biochemical and Biophysical Research Communications. 314 (1): 97–103. doi:10.1016/j.bbrc.2003.12.054. PMID 14715251.
  • Wang L, Banerjee S (Jun 2004). "Differential PIAS3 expression in human malignancy". Oncology Reports. 11 (6): 1319–24. doi:10.3892/or.11.6.1319. PMID 15138572.
  • Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, Meil A, Wojcik J, Legrain P, Gauthier JM (Jul 2004). "Functional proteomics mapping of a human signaling pathway". Genome Research. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
Retrieved from "https://www.wikidoc.org/index.php?title=PIAS3&oldid=1530559"